Revisited Hyperoxia Pathophysiology in the Perioperative Setting: A Narrative Review by Busani, Stefano et al.
MINI REVIEW
published: 22 October 2021
doi: 10.3389/fmed.2021.689450













This article was submitted to
Intensive Care Medicine and
Anesthesiology,
a section of the journal
Frontiers in Medicine
Received: 31 March 2021
Accepted: 22 September 2021
Published: 22 October 2021
Citation:
Busani S, Sarti M, Serra F, Gelmini R,
Venturelli S, Munari E and Girardis M
(2021) Revisited Hyperoxia
Pathophysiology in the Perioperative




in the Perioperative Setting: A
Narrative Review
Stefano Busani 1*, Marco Sarti 1, Francesco Serra 2, Roberta Gelmini 2, Sophie Venturelli 1,
Elena Munari 2 and Massimo Girardis 1
1Cattedra e Servizio di Anestesia e Rianimazione, Azienda Universitaria Policlinico di Modena, Modena, Italy, 2Chirurgia
Generale d’Urgenza e Oncologica, Azienda Universitaria Policlinico di Modena, Modena, Italy
The widespread use of high-dose oxygen, to avoid perioperative hypoxemia along
with WHO-recommended intraoperative hyperoxia to reduce surgical site infections,
is an established clinical practice. However, growing pathophysiological evidence has
demonstrated that hyperoxia exerts deleterious effects on many organs, mainly mediated
by reactive oxygen species. The purpose of this narrative review was to present the
pathophysiology of perioperative hyperoxia on surgical wound healing, on systemic
macro and microcirculation, on the lungs, heart, brain, kidneys, gut, coagulation,
and infections. We reported here that a high systemic oxygen supply could induce
oxidative stress with inflammation, vasoconstriction, impaired microcirculation, activation
of hemostasis, acute and chronic lung injury, coronary blood flow disturbances, cerebral
ischemia, surgical anastomosis impairment, gut dysbiosis, and altered antibiotics
susceptibility. Clinical studies have provided rather conflicting results on the definitions
and outcomes of hyperoxic patients, often not speculating on the biological basis of their
results, while this review highlighted what happens when supranormal PaO2 values are
reached in the surgical setting. Based on the assumptions analyzed in this study, we may
suggest that the maintenance of PaO2 within physiological ranges, avoiding unnecessary
oxygen administration, may be the basis for good clinical practice.
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INTRODUCTION
Oxygen has been a cornerstone of medical care for decades, but also one of the most
misused remedies. Maintaining proper homeostasis between oxygen demand and delivery
is crucial. Oxygen administration has become an established practice in hospital daycare,
although the evidence in favor of its use is rather uncertain. The perioperative period
is one of the phases in which the administration of oxygen reaches its greatest use.
The exposure to transient post-operative hypoxemia caused by pain, excessive sedation,
or other reasons, often justified an even ill-considered use of this medical gas. An
additional reason why anesthesiologists tend to administer high oxygen flows in the
perioperative period is based on the World Health Organization (WHO) guidelines, which
recommend an 80% of inspired oxygen (FiO2) fraction to reduce infections of the surgical
site (SSIs) in adult patients undergoing general anesthesia with tracheal intubation (1).
Although the WHO recommendations from 2016 to 2018 were downgraded from strong to
conditional, the general recommendation to ventilate surgery patients with 80% FiO2 was still
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maintained (2). Alongside this recommendation, the relative
safety of high inspired FiO2 in the surgical patient has favored its
massive use (3). The antimicrobial properties of oxygen are due
to the bactericidal properties associated with increased reactive
oxygen species (ROS) production and were already recognized
in the 1980s - “oxygen as an antibiotic” (4), but recently other
oxygen-related mechanisms have been suggested playing a role
in wound repair (5).
On the contrary, recent randomized controlled trials (RCTs)
conducted in different clinical settings have shown that higher
oxygen delivery negatively affects the outcome of patients (6–8)
while other studies have not shown such negative effects (9, 10).
Hence, a great debate has arisen on the need to administer a
high FiO2 in critically ill, post-operated, or cardiac arrest patients.
The discussion in the scientific community focused mainly on
clinical data deriving from RCTs, but these data hardly provided
a pathophysiological explanation of the mechanism of action of
oxygen during hyperoxia.
Therefore, we aimed to perform a narrative review on
the pathophysiology of high oxygen administration in patients
undergoing surgery, focusing on the effects that hyperoxia
has on surgical wound healing and the systemic macro and
microcirculation, lungs, heart, brain, kidneys, gut, coagulation,
and infections.
METHODS
The pathophysiological evidence for hyperoxia, reported here,
was found through searches in the Medline (PubMed) and
Scopus databases without time limits. We have outlined
the pathophysiological mechanisms, using alternatively
the following keywords “hyperoxia” and “surgical wound”;
“hyperoxia” and “macrocirculation”; “hyperoxia” and
“microcirculation”; “hyperoxia” and “lung” or “pulmonary
circulation”; “hyperoxia” and “heart”; “hyperoxia” and “brain”;
“hyperoxia” and “kidneys” or “erythropoiesis”; “hyperoxia” and
“gut” or “bacterial translocation”; “hyperoxia” and “surgical
anastomosis”; “hyperoxia” and “coagulation”; “hyperoxia”
and “perioperative infections.” The language restriction used
included the acceptance of articles in English only.
This study is a narrative review, and, as such, is being
relatively non-specific from a methodological point of view; it
focuses on articles reporting the pathophysiological aspects of
high oxygen delivery. To provide a simpler understanding to
the reader, we had to shorten the available bibliographic sources,
mainly by discarding papers without a pathophysiological basis,
considering that the terms entered generated a total of over
7,000 results. Moreover, we discarded all the papers regarding
cardiopulmonary bypass and cardiac surgery, because we wanted
to focus mainly on non-cardiac surgery.
WOUND HEALING
Physiological Basis
After surgery, the wound’s healing process is conditioned by
multiple factors, particularly age, patient’s nutritional status,
comorbidities (such as renal insufficiency, oncological disease,
diabetes), and adequate tissue oxygenation. SSI is a frequent
complication after surgery, because of the susceptibility of
the surgical wound to poor oxygen tension. For this reason,
hyperoxia has been considered to reduce the SSI risk.
The surgical incision causes the skin layer’s interruption
and subcutaneous blood vessels dissection, creating ischemia
of the surrounding microenvironment. At the same time,
activation of platelets, coagulative factors, growth factor release,
lymphocytes’, polymorphonuclear, and macrophages chemotaxis
occur. In this complex network, there is a need for increased
oxygen demand due to higher cells’ metabolic activity (11).
Furthermore, activated neutrophils convert oxygen and glucose
into hydrogen ions, superoxide, and lactic acid, resulting in
oxygen consumption equal to 50 times the baseline values
(5). Low oxygen tension could play a role as an early
stimulus for tissue repair, as fibroblasts and endothelial cells
are shown to be affected by hypoxic stimuli in terms of
migration, protein synthesis, and proliferation. On the other
hand, hypoxia leads to poor healing and increases susceptibility
to infections.Most of the available oxygen is then used to perform
antimicrobial functions, collagen synthesis, angiogenesis, and
epithelization (11).
Pathological Consequences
In the first 48 h, neutrophils are the major players in
innate immunity and infection prevention. Their function
depends on the high partial pressure of oxygen (PO2), which
produces ROS, activates phagocytosis and bactericidal defense
against wound pathogens; moreover, as stated above, oxygen
is the substrate used by phagosomal oxidase to catalyze
the formation of the superoxide ion (5). Superoxide is
bactericidal by itself and promotes the ability to kill bacteria
by producing other ROS (5). For these reasons, hyperoxia
plays a crucial role in wound healing; therefore, the whole
process is strictly sensitive to the PO2 in the tissues (5–
12) (Table 1). ROS also enhances the signal transduction
of growth factors such as PDGF, VEGF, and HIF-1, which
stimulates neovascularization, activation of fibroblast, and
collagen deposition (11).
The PROXI randomized clinical trial investigated the
effect of hyperoxia on SSIs within 14 days of surgery; the
authors concluded that there were no significant differences
between the patients receiving a FiO2 of 80% compared
to the group that received a Fi02 of 30%. This conclusion
is still debated because of several study limits, i.e., to
consider in the same group elective and emergency surgery
(44). On the contrary, both Belda et al. (45) that Greif




The cardiovascular effects of hyperoxia are conflicting. The
main confounder in several studies seemed to be the time of
hyperoxia exposure (47). Anyway, however, the unanimously
recognized effect of the enhanced oxidative stress is the systemic
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TABLE 1 | Main pathophysiological mechanisms related to hyperoxia effects (see
text for details).
Wound healing • Neutrophils activation with ROS
production (5)
• Superoxide bactericidal effect (11)
• ROS enhances the signal transduction of
growth factors which stimulates
neovascularization, activation of fibroblast, and
collagen deposition (11)
Macrocirculation • Increase of systemic vascular resistance
due to reduction of NO (13, 14)
• Decrease in Left ventricular
end-diastolic area, Stroke Volume, Cardiac
Output, Heart Rate (15–18)
Microcirculation Decrease in vascular density due to:
• Reduction in NO bioavailability (13)
• Inactivation of potassium and
calcium channels
• Alterations of arachidonic acid metabolism.
• Reduction of the synthesis of vasodilating
prostaglandin (19)
• Microthrombosis (20, 21)
Lungs • Oxidative stress responsible for pulmonary
cellular necrosis and apoptosis (22)
• Damage-associated molecular
patterns release inducing the production
of inflammatory cytokines (22)
• ROS as secondary messenger causing the
activation of other pro-inflammatory
pathways (23)
•Resorption atelectasis and surfactant
alteration (24, 25)
Heart • Coronary blood flow reduction due to
oxidative degradation of coronary
endothelium-derived NO by ROS (26)
• Myocardial ischemia (27–30)
Brain • Contradictory theories on the activation of
apoptotic cascades, neuronal inflammation,
and necrosis (31)
• Decreased cerebral blood flow (32)
Kidneys Controversial results about the association
between intraoperative hyperoxia and
development of AKI during the post-operative
period (33–35)
Erythropoiesis • Hypoxia is the trigger for erytropoietin
production (35)
• “Normobaric oxygen paradox”: a short time
exposure to normobaric hyperoxia followed by
a rapid return to normoxic condition leads to a




• “Gut-Lung Axis”: their bacterial communities
are correlated, and gut microbiota protect the
host during pneumonia (37)
• Oxidative stress impairs bacterial
structure (37)
• Increase of Gram-Negative
Enterobacteriaceae recognized by TLR-4,
involved in necrotizing enterocolitis and in lung
injury (38)
(Continued)
TABLE 1 | Continued
Anastomotic dehiscence Hyperbaric oxygen therapy prevents
anastomotic dehiscence avoiding tissue
ischemia, reducing cytokines’ storm, improving
neovascularization, stimulating stem cells and
growth factors (39, 40)
Coagulation Pro-coagulant effects due to high levels of
plasminogen activator inhibitor-1, high levels of
thrombomodulin, low levels protein C (41)
Perioperative Infections • ROS impair the antibacterial function of
macrophages because of an alteration of the
actin cytoskeleton (42)
• High oxygen levels might influence antibiotic
susceptibility of different pathogens (43)
Legenda: ROS, reactive oxygen species; NO, nitric oxide; AKI, acute kidney injury.
vascular resistances (SVR) increase, with no modifications
observed in norepinephrine serum levels (47). The increase
of SVR seems to be dose-dependent when blood oxygen level
overcomes the physiological range, so there is a linear dose-
response relationship between arterial oxygen and cardiovascular
parameters in supranormal conditions (48). This phenomenon
may be mediated by the direct effect on vessels depending
on the interplay between oxygen and the reduction of the
bioavailability of nitric oxide (NO), an intrinsic vasodilator,
due to serum level increase in ROS (13, 14) (Table 1).
This effect on the vessels has been observed mainly in the
skeletal muscles, which are the main determinant of SVR.
Moreover, a recent experimental report highlighted a decrease
in endothelial cell viability and proliferation under hyperoxia
conditions (49).
Pathological Consequences
Hyperoxia has been observed to increase cardiac
parasympathetic activity as well as arterio-cardiac baroreceptor
reflexes suggesting that peripheral vasoconstriction is the
first event following this neural adaptations (50). Another
effect shown by Bak et al. (48) consists of left ventricular
end-diastolic area (LVEDA) reduction after the exposition
to supraphysiological oxygen levels: this event occurred
without heart rate (HR) reduction suggesting a venous
return and central blood volume decrease. Secondary to
these hemodynamic alterations, this study showed also a
reduction in stroke volume (SV) and cardiac output (CO).
On the contrary, Bodetoft et al. (15) through a magnetic
resonance imaging study reported that LVEDA did not
modify. A decrease in SV and CO was observed in a RCT
on ten healthy volunteers by Yoann Gole et al. (16) during
hyperoxia; after the end of hyperoxic exposure SV and CO
normalization occurred later than HR normalization. A dose-
dependent effect of hyperoxia was also observed in the reduction
of HR. This, associated with the absence of significative
variations of SV, looks like the principal determinant of the
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The effects of hyperoxia on microcirculation are manifold
and have been described on various vascular beds in the
perioperative period. The sublingual vascular bed, thanks to its
easy accessibility, was the one that received the most attention.
Experimental studies on sublingual microvasculature have shown
that with PaO2 increasing there was a progressive decrease
in the vascular density (19, 20). The drop in microcirculatory
perfusion was not associated with cellular hypoxia (e.g., the
lactate value remained constant), but by an increase in SVR
which was explained by multiple mechanisms: reduction in
NO bioavailability due to an increase in ROS, inactivation
of potassium and calcium channels, alterations of arachidonic
acid metabolism, a decrease of cyclooxygenases activity that led
to a reduction of the synthesis of vasodilating prostaglandin
(19) (Table 1). Waisman et al. demonstrated that hyperoxia
administration after splanchnic induced ischemia had beneficial
effects by attenuation of both local and remote inflammatory
microvascular responses (21).
Pathological Consequences
Smit et al. (51), confirming the previous mechanisms, have
added that arteriolar and venularmicrothrombosis occurred after
hyperoxia exposure (Table 1). This underlined the correlation
between the high level of PaO2 and the activation of hemostasis.
Microcirculation alterations become relevant during anemia,
where hyperoxia compromises the compensatory vasodilation
of the microcirculation inducing a decrease of tissue oxygen
delivery and PO2, despite an increase of arterial oxygen content
(52). Mechanisms of skin vasoconstriction related to hyperoxia
are still unclear, but several theories have been proposed.
Yamazaki et al. showed that this may depend on the vasodilating
prostaglandins inhibition and the decrease of NO bioavailability
caused by ROS (13).
LUNG AND PULMONARY CIRCULATION
Physiological Basis
ROS are the main responsible for histological pulmonary
modifications. Their levels increase proportionally to PaO2. The
main source of ROS is presented by oxidative phosphorylation
but also secondary to the stimulation of microbes, cytokines,
and xenobiotics. When the ROS levels overcome those of the
antioxidant defenses appears a condition of oxidative stress
responsible for the damage to fats, proteins, and nucleic acids
that can bring pulmonary cellular necrosis and apoptosis (22).
The ROS-induced damages also determine damage-associated
molecular patterns release that induces the production of
inflammatory cytokines by the neutrophils (Table 1). This
response can be amplified to the point of generating a systemic
inflammatory response syndrome (22). The inflammasome
pattern mediated by ROS also provides for the activation of an
alternative Toll-like receptors (TLRs) pathway culminating in the
activation of the transcription factor nuclear factor-kappaB (NF-
kb), which controls the expression of an array of inflammatory
cytokine genes (53). Huang et al. (54) demonstrated, with an in
vitro study, that intracellular ROS could be an endogenous ligand
for TLR2/4 determining the production of pro-inflammatory
cytokines like IL-6 and IL-8. NF-kb pathways also seem
to regulate the expression of other inflammatory cytokines
like TNF-alpha, MIP-2, PA-1, IL-1beta. Those are essentials
for the first phases of the inflammatory response, while an
increase of HMGB-1 seems to burden the late inflammatory
phase exacerbating the lung injury (55). ROS also acts like
a secondary messenger causing the activation of other pro-
inflammatory pathways. One of these is the MAPK pathway that
has many effects on cellular growth, proliferation, differentiation,
stress response, survival, and apoptosis (56). Many MAPK
intracellular cascades have been described: ERK1/2, JNK, p38,
ERK5 activation. The effects change due to the cell type involved
and duration of exposition (57).
The development of pulmonary circulation is a long and
complex process regulated by several transcription factors and
growth factors during prenatal, as well as postnatal period, in
which many events could happen and alter this process. In
particular, the organs development takes place in a hypoxic
environment, the uterus. Preterm newborns pass from this
condition to a relative hyperoxic postnatal condition (room air).
Moreover, they are usually undergone to mechanical ventilation
with high dose of oxygen to promote the maturation of different
organs. Hyperoxia and ventilation injury cause oxidative stress
and inflammatory response leading to a damage of the lung
vasculature, with common complications of premature babies,
represented by persistent pulmonary hypertension of infants
and bronchopulmonary dysplasia. Hyperoxia and ROS cause a
degradation of the alpha subunit of the transcriptional hypoxia-
inducible factor 1 and the reduction of vascular endothelial
growth factor expression, consequently. This process interrupts
angiogenesis and alveolarization (23).
It is known that the dysregulation of pulmonary vascular
development during the perinatal period leads to pulmonary
vascular disease in adulthood (58). This has been well-studied
in mice with echocardiography and cardiac magnetic resonance:
mice exposed to hyperoxia were characterized by signs of
pulmonary hypertension and right ventricular (RV) dysfunction,
like higher RV pressure, decreased RV stroke volume and low
ejection fractions (59).
Pathological Consequences
The lung is the first organ involved by the toxic effects of
high oxygen concentrations during and after surgery. The
pulmonary oxygen toxicity presents two sequential phases
(60). In the first acute step, interstitial and alveolar edema
formation was observed, due to the pneumocytes type I loss,
lymphatic vessels distention, and inflammatory cells infiltration.
The onset of this condition is dose-dependent related to FiO2
levels: this pathological feature was historically described
in tracheobronchitis and progressive alveolar edema, but a
full regression of these lesions was described (61) after the
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discontinuation of oxygen administration. The second phase,
called proliferative, could be defined as time-dependent; it was
observed in the case of persistence over time of the oxygen
administration. This was characterized by the proliferation
of type II pneumocytes (which replace pneumocytes type
I) causing enlargement of the alveolar epithelial basement
membrane, fibroblastic infiltration appearance, hyaline
membrane formation, macrophagic infiltration appearance,
and alveolar volume (60, 61) reduction. In patients who survive
after prolonged exposition to oxygen, emphysema, atelectasis,
bronchiectasis, and interstitial fibrosis were found. Those
changes, that appeared after the proliferative phase, were not
reversible after the oxygen administration withdrawal. The effects
that have been found are like those observed in patients with
acute respiratory distress syndrome and/or ventilator-induced
lung injury (62). Besides inflammatory effects, other lung tissue
alterations were also observed during high FiO2 administration.
Resorption atelectasis is secondary to the rapid passage of oxygen
from alveoli to capillary blood, with an increased incidence
of postoperative pulmonary and infective complications (24).
Moreover, hyperoxia also leads to surfactant metabolism and
turnover alteration with an increase of the alveolar collapse risk
and compliance impairment (24, 25) (Table 1).
The respiratory mechanics is also affected by hyperoxia in the
perioperative period. During spontaneous breathing after a short
period of hypoventilation, mediated by chemoreceptors in the
carotid bodies, an increase of the minute ventilation secondary to
a rise of tidal volume occurred (63). These changes are not related
to an elevation of the respiratory rate. This response to hyperoxia
is observed also in patients with denervation of carotid bodies,
so it is more likely to be secondary to a central mechanism (e.g.,




As mentioned above, hyperoxia is associated with increased
vascular resistance in the small arteries like the coronary ones,
resulting in coronary blood flow (CBF) reduction and increased
myocardial oxygen consumption. However, the administration
of supplemental oxygen to patients with coronary heart disease
is a common practice based on the idea of helping the
ischemic myocardium, mainly in the post-operative phase. The
arterial oxygen concentration is an important determinant of
coronary artery tone and hypoxia has been described as a strong
vasodilator (26).
Moreover, hemoglobin and myocytes may also play a
role in the regulation of microvascular resistance during
hyperoxia. Hemoglobin acts like a NO-mediated vasodilator in
a deoxygenated environment, while in a high-oxygenated one
it loses this role. Myocytes produce adenosine, which reduces
vascular resistance and increases blood flow in a low-oxygen
situation. In a context of hyperoxia, however, myocytes release
angiotensin I, which brings to the production of endothelin
by the endothelial cells, leading to vasoconstriction (27). The
relation between hyperoxia and cardiac lactate production
is controversial.
Pathological Consequences
McNulty et al. (28) studied 18 patients with stable coronary
heart disease who underwent 100% oxygen by face mask for
15min, showing that the administration of pure oxygen increased
coronary resistance by 40% and decreased CBF by 30%, with a
higher concentration of NO metabolites in the coronary vessels.
The vasoactive oxygen effect could be explained by the fact that
hyperoxia may accelerate the oxidative degradation of coronary
endothelium-derived NO by ROS (Table 1). Since ROS can have
several adverse effects on ischemic myocardium, it is important
to remember that supplemental oxygen administration to
patients with coronary artery disease may increase myocardial
ischemia and worsen myocardial ischemia-reperfusion injury
(29). As adjuvant therapy, the administration of the antioxidant
vitamin C could protect against the reduction in CBF velocity
related to high-concentration oxygen therapy (30).
Guensch et al. (27) demonstrated that the administration of
pure oxygen to patients with the multivessel coronary artery
disease (CAD) was associated with lactate production, due to the
reduction of CBF that increased myocardial ischemia. Moreover,
they demonstrated that 14 of the 25 CAD patients (56%),
hyperoxia induced post stenotic myocardial deoxygenation with
a subsequent oxygenation discordance across the myocardium.
These alterations were accompanied both with cardiac index and
ejection fraction reduction (27).
BRAIN
The impact of hyperoxia on the brain has been extensively
studied in patients with cardiac arrest (64), however, this
narrative review falls outside this clinical context.
Physiological Basis
Excessive supplementation of oxygen could aggravate a primary
or secondary brain injury because of the free radical production
and the activation of apoptotic cascades (31), but in some
preclinical models these considerations have been completely
refuted and even a neuroprotective role was attributed to
hyperoxic conditions (32) (Table 1). A delicate balance exists in
the brain between the useful and harmful effects of oxidative
stress which involves several elements (unsaturated lipid
enrichment, glucose, mitochondria, calcium, glutamate, RNA
oxidation, etc.) to perform different signaling functions (65).
Pathological Consequences
A clinical model studied on the role of hyperoxia is that
of cerebral ischemia, which can represent one of the most
fearful perioperative complications. A retrospective multicenter
cohort study demonstrated an independent correlation between
hyperoxia and higher in-hospital mortality in ventilated stroke
patients. They defined hyperoxia as PaO2 > 300 mmHg, hypoxia
as PaO2 < 60 mmHg or PaO2/FiO2 < 300 mmHg, while the
other cases were considered normoxia (31). Moreover, in healthy
people hyperoxia was associated with an 11–33% reduction of
Frontiers in Medicine | www.frontiersin.org 5 October 2021 | Volume 8 | Article 689450
Busani et al. Hyperoxia in the Surgical Patient
cerebral blood flow, as well as during neurological damage,
as excessive oxygen induces a reduction of oxygen delivery,
worsening the injury. For this reason, the guidelines in critically
neurologic patients indicate a target saturation of 94–98% to
maintain normoxia (66).
The administration of supplemental oxygen is also a common
clinical practice during the management of patients with
subarachnoid hemorrhage (SAH). Asmentioned above, oxidative
stress due to hyperoxia is associated with neuronal inflammation
and necrosis and with decreased cerebral blood flow. After a
subarachnoid hemorrhage, hyperoxia could increase the risk
of developing delayed cerebral ischemia, which is a serious
complication after a SAH, raising the mortality andmorbidity for
survivors. An observational cohort study showed that exposure
to hyperoxia was associated with a three-time-higher risk of
delayed cerebral ischemia and twice the risk of poor 3-month-
neurological outcome in patients with subarachnoid hemorrhage
who required mechanical ventilation (67). Again Reynolds et al.,
in a single-center retrospective cohort study, demonstrated that,
after SAH, early hyperoxia was independently associated with the
occurrence of vasospasm but not with mortality (68). For this
reason, in daily clinical practice, it is necessary to bear in mind




Preterm infants, who are usually exposed to supplemental oxygen
therapy that induces oxidative stress, might have impairment
of organs development, like kidneys, due to this hyperoxic
condition. The results of different studies are controversial. A
pre-clinical study on mice exposed to a normoxic environment
or to a hyperoxic one (65% FiO2), has shown that there are no
immediate and long-term adverse effects of hyperoxia on the
development of glomerular structure in premature neonates (33).
However, a previous study conducted on rats exposed to 80%
FiO2, showed that neonatal hyperoxia causes long term kidney
damage, involved in pathogenesis of hypertension, and reduction
of nephron number (34).
Pathological Consequences
The studies about the effects of perioperative hyperoxia on
acute kidney injury (AKI) in the postoperative days are limited
and controversial. A sub-analysis of a previous trial about
intraoperative supplemental oxygen was conducted to study the
renal outcome of patients undergone to colorectal surgery. They
were divided into two groups: ones were exposed to 30% FiO2
during the surgery, the other one to 80% inspired intraoperative
oxygen. The outcomes were AKI during the first 7 postoperative
days, defined as an increase of serum creatinine > 1.5-fold
or > 0.3 mg/dL, and the maximum postoperative in-hospital
creatinine level. The results showed that there was no correlation




It is well-known that renal tissue hypoxia represents the classic
trigger for erythropoietin (EPO) production (36). In this context,
the “Normobaric oxygen paradox” is a phenomenon that consists
in a short time exposure to normobaric hyperoxia and in a rapid
return to a normoxic condition: this causes a “relative hypoxia”
that stimulates erythropoietin production, through the regulation
of Hypoxia-Inducible Factor 1-alpha expression (69) (Table 1).
Pathological Consequences
A study (69) involving healthy volunteers compared serum
erythropoietin levels in normobaric and hyperbaric oxygen
conditions. In the first case, people breathed normobaric 100%
oxygen for 2 h and the EPO levels measured after 24 and 36H
confirmed the “Normobaric Oxygen Paradox.” In the second
case, the subjects breathed hyperbaric oxygen for 1.5 h in a
hyperbaric chamber, but after 24H a 53% decrease in serum
EPO was registered. The reasons are unclear, but probably a high
level of peripheral oxygen pressure is maintained after hyperbaric
oxygenation and this due to a major quantity of oxygen dissolved
in the plasma and in the renal tissue (69).
Anemia is a common condition of critically ill intensive
care patients, generally caused by inflammatory cytokines that
inhibit the EPO production. A prospective observational study
has examined the efficacy of the normobaric oxygen paradox
in increasing EPO levels in critical patients and the effects of
hyperoxia in terms of oxidative damage, circulating levels of NO,
mROS, and antioxidant. The results show that a 2-h exposure to
hyperoxia in intensive care patients leads to a slight increase in
EPO levels in the next 48 h; a decrease in microvascular perfusion
and elevated serum ROS levels are registered during hyperoxia,
followed by normalization on returning to the baseline FiO2 (37).
GUT AND BACTERIAL TRANSLOCATION
Physiological Basis
The intestinal microbiota supports local mucosal immunity
and represents an important modulator of the immune system,
in fact we can talk about the “Gut-Lung Axis” because their
bacterial communities are correlated, and gut microbiota
might protect the host during pneumonia infections. The
exposure to hyperoxia in mice alters both lung and gut microbial
communities and this condition precedes the oxygen-induced-
lung injury because oxidative stress impairs bacterial structures
(38). In premature neonates, the association between hyperoxia
and postnatal growth restriction, alters the microbiota of
the distal small bowel and cecum, leading to an increase
in pro-inflammatory Gram-negative Enterobacteriaceae:
the recognition of lipopolysaccharide in the cell wall of
Enterobacteriaceae by the host TLR-4 is important in the
pathogenesis of necrotizing enterocolitis. TLR4 signaling is
also involved in lung injury and inflammation (70). Moreover,
hyperoxia might have a positive role during colon surgery. The
surgery manipulation induces oxidative stress in colonic mucosa
because of activation of xanthine oxidase (XO) in enterocytes.
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Pathological Consequences
In a randomized trial, patients undergone elective colon resection
were divided to receiving 30% of FiO2 or 80% FiO2 during
surgery, to determine whether higher oxygen levels might reduce
gut oxidative stress. The results showed that the administration
of 80% FiO2 prevented oxidative stress, with a reduction of
lipid peroxidation and glutathione oxidation; this may be due to
decrease in XO enzymatic activity and XO / (XO + XDH) ratio
in the colonic mucosa (39).
DEHISCENCE OF THE SURGICAL
ANASTOMOSIS
Physiological Basis
The prevention of dehiscence of the surgical anastomosis has
been extensively studied with the use of hyperbaric oxygen
therapy (HBOT). Its positive effects are the improvement of
tissue oxygenation, the reduction of cytokines’ storm, the neo-
vascularization improvement and the stimulation of stem cells
and growth factors (40). On the other hand, it is considered
a low-risk therapy. In some cases, HBOT is applied after
surgery or when the anastomotic dehiscence is already present;
in other cases, it could be used in the preoperative period
as a preconditioning treatment to prevent the complication.
Anyway, there are different and controversial studies about its
use. Tissue ischemia represents the main cause of anastomotic
break, it is possible to obtain an adequate tissue oxygenation with
HBOT (71).
Pathological Consequences
The histopathological evaluation in preoperative and
postoperative treatment on normal and ischemic colonic
anastomoses in rats has shown that HBOT has positive effects
especially on ischemic anastomosis when the treatment is
combined before and after surgical time (71). Conversely,
Fontoura-Andrade et al. have compared pre and postoperative
hyperbaric oxygen therapy on anastomosis in rats, using 100%
oxygen at a maximal pressure of 2.4 atmospheres for 60min in
two preoperative sessions and four postoperative ones. They
concluded that the HBOT does not change the outcome of
anastomosis healing (41). Nowadays, HBOT represents just a
support to prevent anastomotic dehiscence.
COAGULATION
Physiological Basis
The direct effects of hyperoxia on coagulation pathway during
surgery are still unclear. However, the pro-coagulant effects
of the administration of high dose of oxygen are well-known.
Hyperoxic acute lung injury is characterized by a procoagulant
status with high levels of plasminogen activator inhibitor-1 and
thrombomodulin, and low levels of protein C both in plasma and
pulmonary oedema fluid. This leads to impairment of fibrinolysis
(72). The experimental treatment with murine Activated Protein
C was not enough to improve lung injury (72).
Pathological Consequences
If we consider the 28-day in-hospital mortality and new onset
of organ dysfunction in patients with myocardial injury, it has
been evaluated the association between hyperoxia and negative
outcomes with coagulation dysfunction due mainly to a net
decrease in platelets level (73).
PERIOPERATIVE INFECTIONS
As mentioned above, a positive effect of perioperative hyperoxia
is represented by the prevention of surgical wounds infections,
which are sites sensitive to hypoxia.
Physiological Basis
However, it has been demonstrated that hyperoxia creates an
environment rich in free ROS which impairs the antibacterial
function of macrophages. This is due to an alteration of the
actin cytoskeleton with changes in cell morphology, pseudopod
formation and increased cell size. It has been shown that
macrophages exposed to hyperoxia have trouble in phagocytose
and killing of Klebsiella Pneumonia, even if the oxidative
stress leads to production of NO, a free radical involved
in bacterial killing (42). Pseudomonas Aeruginosa represents
one of the major pathogens involved in ventilator-associated
pneumonia in hyperoxic conditions. Again, the exposure to
ROS causes a macrophage damage that results in compromised
Pseudomonas phagocytosis during administration of high
oxygen concentrations (FiO2 ≥95%) as well as during moderate
hyperoxic therapy (FiO2 65%). It has been shown that the
treatment with antioxidant agents preserves actin cytoskeleton
and increases phagocytosis, even in hyperoxic environment (43).
Pathological Consequences
High oxygen levels could influence antibiotic susceptibility of
different pathogens because the standard antibiotic susceptibility
is normally studied on bacteria growth under normal oxygen
conditions. There are several conditions in which oxygen
levels are low such as intra-abdominal abscess, lungs of
cystic fibrosis patients or burn wounds, where the biofilm
formation of pathogens like Pseudomonas Aeruginosa and
Staphylococcus species is facilitated and their tolerance to
antibiotics is increased. At the same time, oxygen therapy
could expose pathogens to high levels of oxygen and alter
their response to antibiotics. Anoxic conditions caused
reduced sensitivity of bacteria to aminoglycoside antibiotics
(74). Oxygen reduction causes a decrease in susceptibility
of Pseudomonas Aeruginosa and Klebsiella Pneumoniae
to Piperacillin/Tazobactam and Azithromycin, respectively.
Conversely, high oxygen concentration decreases the power
of tetracyclines to kill bacteria. For these reasons, it might be
important to also evaluate the oxygen condition of the infection
site to choose the antibiotics to administer during and after
surgery (74).
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CONCLUSIONS
The use of oxygen at high doses to avoid post-operative
hypoxemia together with suggested hyperoxia to reduce SSI are
common clinical practices. However, both of these habits must
be carefully counterbalanced by growing pathophysiological
evidence that highlights the damage of hyperoxia on
different organs. High systemic oxygen delivery may induce
oxidative stress, vasoconstriction, altered microperfusion, lung
injury, hemodynamic impairments, brain ischemia, surgical
anastomosis impairment, gut dysbiosis, and altered antibiotics
susceptibility. Clinical trials, to date, have given rather conflicting
results on the definitions and outcome of hyperoxic patients;
however, the pathophysiological basis of supranormal values
of PaO2 appear deleterious, so the maintenance of PaO2
within physiological ranges, avoiding the administration of
unnecessary oxygen, should represent one of the cornerstones of
“good medicine.”
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